Eli Lilly And Co logo

LLY - Eli Lilly And Co Share Price

$139.58 -1.9  -1.3%

Last Trade - 17/01/20

Sector
Healthcare
Size
Large Cap
Market Cap £103.03bn
Enterprise Value £113.52bn
Revenue £17.41bn
Position in Universe 74th / 6410
Bullish
Bearish
Unlock LLY Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

LLY Revenue Unlock LLY Revenue

Net Income

LLY Net Income Unlock LLY Revenue

Normalised EPS

LLY Normalised EPS Unlock LLY Revenue

PE Ratio Range

LLY PE Ratio Range Unlock LLY Revenue

Dividend Yield Range

LLY Dividend Yield Range Unlock LLY Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
LLY EPS Forecasts Unlock LLY Revenue
Profile Summary

Eli Lilly and Company is engaged in drug manufacturing business. The Company discovers, develops, manufactures and markets products in two segments: human pharmaceutical products and animal health products. The Company's human pharmaceutical business segment sells medicines, which are discovered or developed by its scientists. Its animal health business segment develops, manufactures and markets products for both food animals and companion animals. The Company's human pharmaceutical products include endocrinology products, neuroscience products, oncology products, immunology products and cardiovascular products. The Company's animal health products segment includes products for food animals and products for companion animals. As of December 31, 2018, the Company manufactured and distributed its products through facilities in the United States, Puerto Rico and 14 other countries.

Directors
Last Annual December 31st, 2018
Last Interim September 30th, 2019
Incorporated January 17, 1901
Public Since July 9, 1970
No. of Shareholders: 24,000
No. of Employees: 38,680
Sector Healthcare
Industry Pharmaceuticals
Index FTSE Global 100, S&P Composite 1500 , S&P 500 , S&P 500 Health Care (sector),
Exchange New York Stock Exchange
Shares in Issue 960,130,771
Free Float (0.0%)
Eligible for
ISAs
SIPPs
LLY Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for LLY
Upcoming Events for LLY
Similar to LLY
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.